Posted by Scott L. Schofield on December 12, 1999, at 11:43:51
In reply to Re: amineptine no longer available, posted by Bruce on December 10, 1999, at 10:47:07
> > > Amineptine is no longer available at IAS or anywhere else I know of. I think the manufacturer stopped making it for some reason.
> > Does it mean it's no longer available in Europe? Anyway, I was wondering how it can be helpful for depression with the tendency toward OCD and phobia? I know that it works by taking the serotonin out of the system.
> Amineptine has too much abuse potential for most governments. I think IAS got theirs from Thailand (!) and maybe the Thai gov't just said no.
What about all the new benzodiazepines? It seems silly to allow these drugs to be marketed when others of potentially great benefit for other indications are denied approval because of far less abuse potential.
Why is Wellbutrin (bupropion) not available in the U.K. or Canada?
> Amineptine potentiates dopamine. Anna may be thinking of a related drug, tianeptine, which actually *reduces* the inter-cellular concentrations of serotonin. It's the exact opposite strategy of an SSRI - yet it seems to work (in about 70% of patients, just like every other drug out there). It shows how far we have to go towards understanding just what is going on in depression.
Sometime it seems as if pushing the system in one direction or the other forces a "reset" of the "thermostats".
- Scott
poster:Scott L. Schofield
thread:611
URL: http://www.dr-bob.org/babble/19991212/msgs/16758.html